首页> 外文期刊>The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease >Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan
【24h】

Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan

机译:哈萨克斯坦危险因素趋同,但艾滋病毒感染与耐多药结核病之间没有关联

获取原文
获取原文并翻译 | 示例
           

摘要

SETTING: Kazakhstan is a country with a low HIV/ AIDS (human immunodeficiency virus/acquired immunedeficiency syndrome) burden, but a high prevalence of multidrug-resistant tuberculosis (MDR-TB). METHODS: We describe the epidemiology of multidrug resistance and HIV among TB patients, using the 2007- 2011 national electronic TB register. RESULTS: HIV test results were available for 97.2% of TB patients. HIV prevalence among TB patients increased from 0.6% in 2007 to 1.5% in 2011. Overall, 41.6% of patients had a positive smear at diagnosis, 38.6% a positive culture and 51.7% either a positive smear or culture. Drug susceptibility testing (DST) results were available for 92.7% of culture-positive cases. Socio-economic factors independently associated with both HIV and MDR-TB were urban residency, drug use, homelessness and a history of incarceration. In adjusted analysis, HIV positivity was not associated with MDRTB (OR 1.0, 95%CI 0.86-1.2). Overall, among TB patients with DST and HIV test results available, 65.0% were positive for neither HIV nor MDR-TB, 33.5% only for MDR-TB, 0.9% only for HIV and 0.6% for both HIV and MDR-TB. Among injection drug users, 12.5% were positive for HIV and MDR-TB. CONCLUSION: We showed increasing HIV prevalence among TB patients in Kazakhstan. HIV was not an independent risk factor for MDR-TB, but risk factors were largely overlapping and we did identify subgroups at particular risk of HIV-MDR-TB co-infection, notably drug users. Enhanced efforts are necessary to provide care to these socially vulnerable populations.
机译:地点:哈萨克斯坦是一个艾滋病毒/艾滋病(人类免疫缺陷病毒/后天免疫缺陷综合症)负担低,但耐多药结核病(MDR-TB)患病率高的国家。方法:我们使用2007-2011年国家结核病电子登记系统,描述了结核病患者多药耐药性和HIV的流行病学。结果:97.2%的结核病患者可获得HIV检测结果。结核病患者中的艾滋病毒患病率从2007年的0.6%增加到2011年的1.5%。总体而言,诊断时涂片阳性的患者为41.6%,培养阳性的患者为38.6%,涂片或培养阳性的患者为51.7%。 92.7%的培养阳性病例可获得药敏试验(DST)结果。与艾滋病毒和耐多药结核病独立相关的社会经济因素是城市居住,吸毒,无家可归和有监禁史。在调整后的分析中,HIV阳性与MDRTB不相关(OR 1.0,95%CI 0.86-1.2)。总体而言,在具有DST和HIV检测结果的结核病患者中,HIV和MDR-TB均为65.0%阳性,仅MDR-TB为33.5%,HIV为0.9%,HIV和MDR-TB均为0.6%。在注射吸毒者中,艾滋病毒和耐多药结核病阳性率为12.5%。结论:我们发现哈萨克斯坦的结核病患者中艾滋病毒感染率上升。艾滋病毒不是耐多药结核病的独立危险因素,但是危险因素在很大程度上是重叠的,我们确实确定了艾滋病毒-耐多药结核病合并感染的特别危险人群,尤其是吸毒者。必须加大努力为这些社会弱势群体提供护理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号